(Q67485508)
Statements
A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer (English)
M Fukuoka
H Niitani
A Suzuki
M Motomiya
K Hasegawa
Y Nishiwaki
T Kuriyama
Y Ariyoshi
S Negoro
1 January 1992